Auctus Fund, LLC 13D and 13G filings for BioRestorative Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 3:12 pm Purchase | 2025-06-30 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund, LLC | 784,655 9.900% | 25,568 (+3.37%) | Filing |
| 2025-05-15 11:32 am Purchase | 2025-03-31 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund, LLC | 759,087 9.900% | 66,669 (+9.63%) | Filing |
| 2024-11-14 12:33 pm Purchase | 2024-09-30 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund, LLC | 692,418 9.900% | 210,103 (+43.56%) | Filing |
| 2024-02-14 1:44 pm Purchase | 2023-12-31 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund, LLC | 482,315 9.900% | 106,311 (+28.27%) | Filing |
| 2023-02-14 1:02 pm Purchase | 2022-12-31 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund, LLC | 376,004 9.900% | 166,004 (+79.05%) | Filing |
| 2022-07-14 5:26 pm Purchase | 2022-06-30 | 13G | BioRestorative Therapies, Inc. BRTX | Auctus Fund, LLC | 210,000 5.800% | 210,000 (New Position) | Filing |